BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30504380)

  • 21. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion.
    Han HS; Jo YN; Lee JY; Choi SY; Jeong Y; Yun J; Lee OJ
    Oncol Lett; 2014 Oct; 8(4):1889-1895. PubMed ID: 25202432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.
    Yang Y; Ma L; Qiao X; Zhang X; Dong SF; Wu MT; Zhai K; Shi HZ
    Transl Lung Cancer Res; 2020 Aug; 9(4):1247-1257. PubMed ID: 32953502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
    Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
    J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
    Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
    Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
    Zhang X; Bao L; Yu G; Wang H
    Front Surg; 2022; 9():1050242. PubMed ID: 36684253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
    Xu CH; Zhan P; Yu LK; Zhang XW
    Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in
    Xie T; Wang Q; Gao J; He K; Yu J
    Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology.
    Cappellesso R; Nicolè L; Caroccia B; Guzzardo V; Ventura L; Fassan M; Fassina A
    Cancer Cytopathol; 2016 Jan; 124(1):28-37. PubMed ID: 26765063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.
    Wang T; Lv M; Shen S; Zhou S; Wang P; Chen Y; Liu B; Yu L; Hou Y
    PLoS One; 2012; 7(8):e43268. PubMed ID: 22937028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant pleural effusion cells show aberrant glucose metabolism gene expression.
    Lin CC; Chen LC; Tseng VS; Yan JJ; Lai WW; Su WP; Lin CH; Huang CY; Su WC
    Eur Respir J; 2011 Jun; 37(6):1453-65. PubMed ID: 20884743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of microRNA-93 regulating angiopoietin2 in the formation of malignant pleural effusion.
    Qian Q; Sun W; Zhu W; Liu Y; Ge A; Ma Y; Zhang Y; Zeng X; Huang M
    Cancer Med; 2017 May; 6(5):1036-1048. PubMed ID: 28401709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma.
    Huang X; Zhou H; Yang X; Shi W; Hu L; Wang J; Zhang F; Shao F; Zhang M; Jiang F; Wang Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24777. PubMed ID: 36426920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.